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The participation of community pharmacists in the 
case management of malaria in Enugu metropolis, 




Nigeria accounts for approximately 25% of  the global malaria burden. Malaria is a major cause of  morbidity and mortality, especially 
in children and pregnant women. Pharmacists play vital roles in the fight against malaria. However, in Nigeria, the role of  the 
community pharmacist in managing cases of  malaria has received very little research attention. This study aimed to evaluate the 
level of  participation of  community pharmacists in the management of  malaria cases in Enugu metropolis and to explore factors 
associated with such participation.
Methods
A cross-sectional survey was conducted among community pharmacists in Enugu metropolis using a modified and re-validated 
16-item self-administered questionnaire. The questionnaire was distributed to participants in selected pharmacies for completion. 
Descriptive statistics and the chi-square test were used for statistical analysis. 
Results 
Out of  the 103 participants, more than half  (55.3%) were male. More than half  of  the pharmacists satisfactorily provided preventive 
(57.3%), pharmaceutical (62.1%), and curative (51.1%) services for patients with malaria. Overall, 57% of  the pharmacists satisfactorily 
participated in the management of  malaria cases. The number of  years of  practice was significantly associated with the pharmacists 
level of  involvement in preventive (P=0.003) and curative (P=0.018) services. However, the provision of  pharmaceutical care services 
for malaria patients was significantly associated with the sex   of  the respondents (P=0.023).
Conclusions
Our results suggest that more than half  of  the community pharmacists in Enugu metropolis were satisfactorily involved in the 
management of  malaria cases. However, the number of  years of  practice and sex were factors associated with the extent of  pharmacist 
involvement in the management of  malaria cases. 
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Introduction
In Nigeria, malaria is still an important cause of  morbidity 
and mortality, especially in infants, children, and pregnant 
women. According to the World Health Organization 
(WHO), Nigeria accounts for approximately 25% of  the 
world’s malaria burden. An estimated 57.3 million cases 
and 100,700 malaria-related deaths were reported in West 
African countries in 20161. Previous research showed that 
malaria is the primary reason for almost 60% of  outpatient 
hospital visits and approximately 30% of  hospitalized 
patients. Furthermore, approximately 50% of  the Nigerian 
population is known to suffer at least one episode of  malaria 
attack annually. In contrast, children less than 5 years old 
experienced an average of  2–4 attacks of  malaria per year. 
Additionally, a large portion of  the population, approximately 
100 million people, are at risk of  malaria on a yearly basis1,2.
Community pharmacists appear to be the most accessible 
health care professionals, thus, making them the right 
partners for the prevention, control, and treatment of  
malaria. Pharmacists are experts in the use of  medications. 
They possess the knowledge and skills required to ensure 
the safe and effective use of  medicines. Community 
pharmacists are responsible for the supply of  medicines 
and the counselling of  patients and caregivers with regards 
to the rational use of  drugs. Also, community pharmacists 
are becoming increasingly involved in health promotion and 
education3-5. These enhanced roles are targeted at helping 
patients (or clients) to achieve optimal outcomes from drug 
therapy and pharmaceutical services and to ensure that 
patients live a healthy life6. 
Presently, in many parts of  the world, pharmacists are 
encouraged to deliver pharmaceutical services that are centred 
on the patient’s health care needs5,7,8. Globally, in the past, 
community pharmacy practice was limited primarily to drug 
preparation, dispensing, and patient counseling9. However, 
in recent years, pharmacy practice has evolved from the 
traditional product-oriented profession to patient-focused 
practice worldwide, thus, giving rise to the development 
of  the concept of  pharmaceutical care (PC)10. PC is the 
direct, responsible provision of  medication-related care 
to achieve definite outcomes that improve and maintain a 
patient’s quality of  life10. The pharmacist takes responsibility 
for meeting the drug needs of  the patients while showing 
personal concern for his or her wellbeing. In the PC 
Malawi Medical Journal 32 (4); 218-225 December 2020 Malaria case management for pharmacists  219
https://dx.doi.org/10.4314/mmj.v32i4.7
practice model, the pharmacist works in collaboration with 
the patient, caregiver, and other health care professionals 
to achieve definite outcomes in the overall interest of  the 
patient10. 
In Nigeria, community pharmacies are usually the first point 
of  contact within the health care system for the purchase of  
medications and the management of  minor health problems, 
including malaria. Despite inherent challenges, pharmacy 
practice in Nigeria has also changed to mirror international 
best practices11,12. The community pharmacies are an integral 
aspect of  the primary health care system in Nigeria. Because 
of  the growing burden of  diseases in Nigeria, the National 
Treatment Policy adopted from the WHO and published 
by the Ministry of  Health allows community pharmacists 
to diagnose and treat minor ailments, such as malaria, 
typhoid, and the common cold2,13-16. Pharmacists prescribe 
and dispense over-the-counter medications, including anti-
malarial drugs. Also, pharmacists conduct dipstick rapid 
diagnostic tests and clinical patient assessments for patients 
with a suspected case of  malaria and anaemia17. Patients 
and other clients visit community pharmacies to access 
medications and medication-related services, and they pay 
for medications to be dispensed in the course of  their 
treatment. Nevertheless, the medication-related services 
provided by community pharmacists, including malaria case 
management, are not remunerated either by the recipients 
or any third party18. At present, there is no specific legal 
framework to back these additional roles for the pharmacist, 
and the practice is not yet uniform across all regions of  the 
country19.
In malaria-endemic regions, community pharmacists are 
well positioned to assist in surmounting the problem of  
inappropriate anti-malarial drug use, irrational prescribing, 
and the anti-malarial drug resistance that impedes the 
attainment of  desired malaria elimination. Pharmacists 
also carry out a range of  other duties including health 
promotion and education aimed at addressing the inability 
to access preventive care facilities, the presence of  stagnant 
water around homes, and the improper disposal of  waste 
materials20. However, in Nigeria, the involvement of  
community pharmacists in the provision of  primary health 
care in general and malaria-specific services, in particular, has 
received very little research attention. Therefore, the purpose 
of  this study was to determine the level of  participation of  
community pharmacists in the provision of  preventative 
malaria services, PC for malaria patients, and curative 
services for malaria in Enugu metropolis, Nigeria, and to 
explore factors associated with this practice.
Methods 
This research study was a cross-sectional study conducted 
among community pharmacists in Enugu metropolis, Nigeria. 
Enugu metropolis is the capital city of  Enugu State, located 
in the Southeastern region of  Nigeria. Geographically, the 
state is located within latitude 6°.00′N and 7°.00′N, and 
longitude of  7°.00′E and 7°.45′E. Overall, Enugu metropolis 
is mainly warm and wet, with annual heavy downpours 
from March to September. Thus, the climatic condition 
of  Enugu metropolis is one that encourages the breeding 
of  plasmodium-carrying vectors. Furthermore, the study 
location has a dense mixed population of  over 3.2 million, 
comprising various ethnic groups in Nigeria. However, the 
Igbos are the predominant tribe.
There were 120 community pharmacies registered with the 
Pharmacists Council of  Nigeria in Enugu State as at the 
time of  the study. Out of  the 120 community pharmacies 
in Enugu metropolis distributed across three zones, 60 
community pharmacies were selected from across the zones; 
30 new and 30 old pharmacies to ensure fair representation. 
Based on the Pharmacists Council of  Nigeria Guidelines for 
the Registration of  Premises, we considered pharmacies less 
than 5 years of  existence as new pharmacies and those above 
as old pharmacies. Two pharmacists were recruited per 
community pharmacy outlet. Based on the records of  the 
Pharmacists Council of  Nigeria, there were 172 registered 
community pharmacists in Enugu metropolis at the time of  
the study. The convenience sampling technique was used for 
the recruitment of  study participants. The inclusion criteria 
for recruiting participants were as follows: (1) pharmacists 
who are registered with the Pharmacists Council of  Nigeria, 
and (2) those who gave informed consent to participate in 
the study. However, intern pharmacists, pharmacy trainees, 
and pharmacy technicians were excluded from the study.
The study instrument used was a modified re-validated 
self-administered questionnaire adopted from Osemene 
and colleagues and the WHO’s operational manual on 
malaria case management21,22. Face validity, content validity, 
and reliability tests, were performed after drafting the 
questionnaire items. The Cronbach’s alpha (α=0.73) of  the 
survey instrument was within an acceptable limit. Generally, 
the questionnaire had two sections. The first section 
contained information on the respondents’ demographic 
and practice characteristics that comprised sex, age, years of  
practice, the previous area of  practice, highest qualification, 
position of  the pharmacist, ownership of  the pharmacy, and 
type of  community pharmacy. The second section consisted 
of  a 16-item questionnaire, divided into three domains. The 
domains were as follows: (1) malaria preventive services (5 
items), (2) PC services for malaria patients (5 items), and (3) 
malaria curative services (6 items). Each item was measured 
on a 5-point Likert scale (not at all = 1, less frequent = 2, 
not sure = 3, frequent = 4, and very frequent = 5). The 
summation of  scores represents the level of  performance 
since all the items on the instrument were positively worded 
and in one direction. The extent of  pharmacist involvement 
in the management of  malaria cases was classified as either 
high or low based on whether the sum score was above or 
below the population mean score. Thus, a high variable score 
correlates with a high level of  performance and an invariably 
high level of  community pharmacist involvement in malaria 
prevention, PC, and curative services, and vice versa.
Data collection
The self-administered questionnaire was distributed to 
community pharmacists in selected pharmacies by the 
researchers and three trained research assistants. The 
completed questionnaires were retrieved immediately after 
completion in the pharmacy premises. Questionnaires from 
respondents who were unable to complete the questionnaire 
instantly were retrieved on a follow-up visit within 1 week. 
Overall, the questionnaires were completed in approximately 
15 minutes. The period of  data collection lasted from 18 
May 2018 to 27 July 2018. 
Data analysis
The variables were coded and entered into Microsoft 
Excel 2010, where the data were cleaned and checked for 
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appropriateness. In coding the variables, a sequential number 
was given to the variables. The highest score on the 5-point 
Likert scale was assigned ‘5’, while the lowest score was 
assigned ‘1’. For the 5-item domains, the lowest possible 
score would be 5 while the highest possible score would 
be 25. However, for the 6-item domain, the lowest possible 
score would be 6, while the highest possible score would 
be 30. Descriptive statistics (frequency, percentage, mean, 
and standard deviation) was used to present demographic 
variables, practice characteristics, and item responses. The 
chi-square test was used to examine the association between 
dependent variables (the level of  involvement in malaria 
prevention, PC, and curative services) and independent 
variables (demographic and practice characteristics). The 
percentage performance was the proportion of  respondents 
that scored above the mean population. Thus, the level of  
involvement was categorized into high extent (scores > mean 
population) and low extent (scores < mean population). All 
statistical analyses were performed using IBM Statistical 
Product and Service Solution (SPSS) for Windows, version 
21.0 (IBM Corp, version 21.0, Armonk, NY, USA). The level 
of  statistical significance (α) was set at P<0.05.
Ethical considerations
Ethical approval for this study was obtained from the 
National Health Research and Ethical Committee of  the 
University of  Nigeria Teaching Hospital, Ituku-Ozalla, 
Enugu State on 16 May 2018, with the approval number 
NHREC/05/01/2008B-FWA00002458-IRB00002323. 
Prior to study initiation, written informed consent was 
obtained from all eligible participants. The participants 
were assured of  strict confidentiality in handling all of  the 
responses provided.
Results
Demographic and practice characteristics
Table 1 shows the demographic and practice characteristics 
of  the pharmacists. Out of  the 120 pharmacists recruited 
for the study, 103 questionnaires were returned completed, 
giving a response rate of  85.8%. The sex distribution of  the 
respondents revealed that more than half  (55.3%) were male. 
Nearly half  of  the respondents (46.6%) were aged 31–45 
years and had at least 16 years of  practice experience. The 
majority of  the respondents were superintendent pharmacists 
(71.8%) and had a bachelor’s degree in pharmacy (78.8%) as 
their highest qualification. Most of  the pharmacists (92.2%) 
practiced in independent community pharmacies.
Level of involvement in the case management of 
malaria
Table 2 shows the item analysis for the level of  involvement 
in malaria case management in terms of  malaria preventive 
services, PC services, and curative services. More than half  
of  the pharmacists were satisfactorily involved in providing 
malaria preventive services (57.3%), PC services to malaria 
patients (62.1%), and malaria curative services (51.5%). 
Overall, approximately 57.0% of  the pharmacists in this 
study had a satisfactory level of  participation in managing 
malaria cases.
Association of demographic and practice 
characteristics with the level of participation in 
preventive malaria services
Table 3 illustrates the relationship between the level of  
participation of  community pharmacists in preventive malaria 
services and the demographic and practice characteristics of  
the respondents. The results showed a significant association 
between the level of  participation in preventive malaria 
services and the number of  years of  practice (χ2=15.739, 
P=0.003).
Table 1. Demographic and practice characteristics of pharmacists 
(n=103)
The association of demographic and practice 
characteristics with the level of participation in 
the provision of pharmaceutical care for malaria 
patients
Table 4 shows the association between the level of  
participation of  pharmacists in the provision of  PC for 
malaria patients and their demographic and practice variables. 
The results indicate a significant association between sex and 
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for malaria patients (χ2=5.204, P=0.023). However, the 
involvement of  pharmacists in PC services was independent 
of  other demographic and practice variables (Table 4). 
Table 2. Item analysis of the level of pharmacist 
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Mean total 3.90 0.90 57.3
Pharmaceutical care 
services
(1) Prompt services to 
malaria patients 4.19 0.78
55.4
(2) Provision of anti-
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Mean total 3.77 0.90 62.1
Curative services
(1) Prompt diagnosis of 
malaria 4.28 0.81
63.7
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(4) Prompt and effective 





malarial drug resistance 2.42 0.92
39.8
(6) Reports adverse 
drug reactions 





Mean total 3.15 0.97 51.5
Grand mean total 3.61 0.92 57.0
Table 3. The association of the level of involvement of community 
pharmacists in preventative malaria services and sociodemographic 
and practice characteristics
Association of demographic and practice 
characteristics with the level of participation in 
malaria curative services
Table 5 shows the association between the level of  
participation of  pharmacists in curative malaria services and 
their demographic and practice characteristics. The number 
Characteristics Performance, n (%) χ2 P value
High extent Low extent
Sex
Male 32 (31.1) 25 (24.3) 0.068 0.794
Female 27 (26.2) 19 (18.4)
Age (years)
25–30 5 (4.9) 9 (8.7) 5.358 0.147
31–45 30 (29.1) 18 (17.5)
46–60 18 (17.5) 9 (8.7)
>60 6 (5.8) 8 (7.8)
Years of 
practice
0–5 7 (6.8) 16 (15.5) 15.739 0.003*
6–10 14 (13.6) 2 (1.9)
11–15 6 (5.8) 8 (7.8)
16–20 17 (16.5) 7 (6.8)
>20 15 (14.6) 11 (10.7)
Previous area 
of practice 
Academia 0 (0.0) 2 (1.9) 5.701 0.336
Hospital 19 (18.4) 17 (16.5)
Administrative 3 (2.9) 3 (2.9)
Sales 
representative
14 (13.6) 12 (11.7)
Industry 1 (1.0) 0 (0.0)
None 22 (21.4) 10 (9.7)
Highest 
qualification
B.Pharm 42 (40.8) 35 (34.0) 1.370 0.504
Pharm.D 6 (5.8) 2 (1.9)
M.Pharm 11 (10.7) 7 (6.8)
Position of 
pharmacist
Superintendent 42 (41.2) 32 (31.4) 0.001 0.972
Part-time 17 (15.7) 12 (11.7)
Ownership
Employer 37 (35.9) 26 (25.2) 0.139 0.709
Employee 22 (21.4) 18 (17.5)
Type of 
pharmacy
Chain 5 (4.9) 3 (2.9) 0.097 0.756
Independent 54 (52.4) 41 (39.8)
*Significant at P<0.05.
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Table 5. The association of the level of involvement of community 
pharmacists in malaria curative services and sociodemographic 
and practice characteristics
Discussion
The findings of  the present study demonstrated that more 
than half  of  the community pharmacists satisfactorily 
provided preventive care services in their pharmacy premises. 
Generally, the community pharmacists are seen as a quick 
source of  advice, referral, medicines, and information, by 
patients and other clients23. Pharmacists are expected to 
of  years of  practice was significantly associated with the level 
of  involvement in the provision of  curative malaria services 
(χ2=11.883, P=0.018).
Table 4. Association of the level of involvement of community 
pharmacists in pharmaceutical care services and sociodemographic 
and practice characteristics
Characteristics Performance, n (%) χ2 P value
High extent Low extent
Sex
Male 41 (39.8) 16 (15.5) 5.204 0.023*
Female 23 (22.3) 23 (22.3)
Age (years)
25–30 9 (8.7) 5 (4.9) 2.350 0.503
31–45 27 (26.2) 21 (20.4)
46–60 17 (16.5) 10 (9.7)
>60 11 (10.7) 3 (2.9)
Years of 
practice
0–5 13 (12.6) 10 (9.7) 0.897 0.925
6–10 9 (8.7) 7 (6.8)
11–15 9 (8.7) 5 (4.9)
16–20 16 (15.5) 8 (7.8)
>20 17 (16.6) 9 (8.7)
Previous area 
of practice 
Academia 1 (1.0) 1 (1.0) 6.285 0.279
Hospital 23 (22.3) 13 (12.6)
Administrative 4 (3.9) 2 (1.9)
Sales 
representative
20 (19.4) 6 (5.8)
Industry 0 (0.0) 1 (1.0)
None 16 (15.5) 16 (15.5)
Highest 
qualification
B.Pharm 48 (46.6) 29 (28.2) 0.659 0.719
Pharm.D 4 (3.9) 4 (3.9)
M.Pharm 12 (11.7) 6 (5.8)
Position of 
pharmacist
Superintendent 48 (47.1) 26 (25.5) 1.097 0.295
Part-time 16 (14.7) 13 (12.7)
Ownership
Employer 38 (36.9) 25 (24.3) 0.228 0.633
Employee 26 (25.2) 14 (13.6)
Type of 
pharmacy
Chain 6 (5.8) 2 (1.9) 0.610 0.435
Independent 58 (56.3) 37 (35.9)
*Significant at P<0.05.
Characteristics Performance, n (%) χ2 P 
valueHigh extent Low extent
Sex
Male 32 (31.1) 25 (24.3) 1.121 0.290
Female 21 (20.4) 25 (24.3)
Age (years)
25–30 4 (3.9) 10 (9.7) 3.782 0.286
31–45 25 (24.3) 23 (22.3)
46–60 16 (15.5) 11 (10.7)
>60 8 (7.8) 6 (5.8)
Years of practice
0–5 6 (5.8) 17 (16.5) 11.883 0.018*
6–10 10 (9.7) 6 (5.8)
11–15 10 (9.7) 4 (3.9)
16–20 10 (9.7) 14 (13.6)
>20 17 (16.5) 9 (8.7)
Previous area of 
practice 
Academia 1 (1.0) 1 (1.0) 3.425 0.635
Hospital 15 (14.6) 21 (20.4)
Administrative 3 (2.9) 3 (2.9)
Sales 
representative
16 (15.5) 10 (9.7)
Industry 1 (1.0) 0 (0.0)
None 17 (16.5) 15 (14.6)
Highest 
qualification
B.Pharm 37 (35.9) 40 (38.8) 4.089 0.129
Pharm.D 3 (2.9) 5 (4.9)
M.Pharm 13 (12.6) 5 (4.9)
Position of 
pharmacist
Superintendent 40 (39.2) 34 (33.3) 1.019 0.313
Part-time 13 (11.8) 16 (15.7)
Ownership
Employer 30 (29.1) 33 (32.0) 0.956 0.328
Employee 23 (22.3) 17 (16.5)
Type of 
pharmacy
Chain 4 (3.9) 4 (3.9) 0.007 0.932
Independent 49 (47.6) 46 (44.7)
*Significant at P<0.05.
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provide preventive care services that include the promotion 
of  personal and environmental hygiene, malaria awareness, 
the detection of  early signs and symptoms of  malaria, the 
provision of  intermittent preventive treatment services 
for pregnant women, and the use of  insecticide-treated 
nets as a protective measure against malaria vectors22. The 
involvement of  community pharmacists in preventive care 
services in the present study was better compared to a 
related study conducted in Nigeria by Oparah and Arigbe-
Osula24. In this earlier study, it was reported that less than 
one-third of  the pharmacists (31%) surveyed in Benin 
city were involved in preventive services24. Likewise, a 
study in the United Kingdom reported poor involvement 
of  community pharmacists in activities related to disease 
prevention and health promotion25. However, a higher 
proportion of  community pharmacists (77%) participated in 
the provision of  preventive services directed against malaria 
in Jalingo, North-east Nigeria21. Also, a study in Lagos, South-
west Nigeria reported high levels of  participation from 
pharmacists in health promotion and disease prevention. In 
the study, for instance, approximately 89% of  the community 
pharmacists were involved in health education and leaflet 
provision26. The possible explanation for the findings of  the 
current study could be that community pharmacists in the 
study location have not truly understood the relevance of  
malaria preventive services in the health care delivery system. 
Many pharmacists in the present study might have shown 
apathy towards the provision of  preventative malaria services 
because they do not get reimbursed for such services by the 
patients, caregivers, community leaders, third-party payers, or 
the government. However, there is still hope for the future as 
a previous study reported that most community pharmacists 
(84%) in two Nigerian cities have favourable attitudes towards 
health promotion27. Therefore, policies and initiatives geared 
towards encouraging community pharmacists to provide 
preventative malaria services in Nigeria should be promoted 
by health policymakers and other stakeholders in the health 
sector.
We also found that approximately 62% of  the pharmacists 
satisfactorily provide PC for malaria patients. In contrast to 
the findings of  the current study, however, previous research 
in Nigeria reported poor and grossly inadequate levels of  
pharmacist participation and the quality of  PC rendered 
to malaria patients21. Nevertheless, other studies reported 
positive attitudes and appreciably high levels of  involvement 
for community pharmacists in rendering PC to patients in 
general28,29. Globally, in recent years, the focus of  pharmacy 
practice has changed from a product-oriented profession to 
a patient-oriented profession. The community pharmacists, 
in particular, are profoundly involved in the patient care 
process. They provide drug-related services that directly 
enable patients to obtain optimal benefit from prescribed 
medications. In doing so, pharmacists take responsibility for 
their actions within the stipulated limits of  the laws of  the 
land where they practice30. The practice of  PC in community 
pharmacies is well established in developed countries such as 
the United Kingdom, the United States, and Canada. However, 
a shortage of  pharmacists, and a lack of  reimbursement 
remain a barrier for its full implementation31. PC practice 
by community pharmacists has been demonstrated to result 
in improved medication adherence, quality of  life, and cost 
savings32. In Nigeria, the existing laws are yet to recognize 
the added roles of  community pharmacists in the health care 
system33. Hence, pharmacists are restricted in the roles they 
can actually perform to assist patients with minor ill-health 
from the legal perspective19.
Furthermore, the current study demonstrated that 
approximately 51% of  community pharmacists offered 
curative services to patients with malaria. This finding might 
appear worrisome, considering that community pharmacists 
are the most accessible and readily available health care 
professionals in the neighbourhood. Many patients seek 
treatment for minor ill-health in community pharmacies. 
However, the findings of  the current study differed 
considerably with those of  two previously published studies 
that reported 80% and 100% involvement of  community 
pharmacists in curative services to malaria patients21,24. The 
WHO recognizes the critical role of  community pharmacists 
in the provision of  treatment services for malaria patients. 
Virtually all anti-malarial drugs used for the treatment of  
malaria are over-the-counter medications. In addition, the 
approval of  the use of  a rapid diagnostic test by WHO in 
community pharmacies to confirm the diagnosis of  malaria 
before treatment eased the challenge of  providing curative 
services in such facilities. Hence, community pharmacists are 
permitted within the ambit of  the law to diagnose, initiate 
treatment, and monitor the outcome of  therapy for patients 
suffering from malaria.
Moreover, we found that level of  pharmacist involvement 
in the provision of  preventative and pharmaceutical malaria 
care services were associated with the number of  years of  
practice. On the other hand, sex was associated with the 
participation of  the respondents in curative services to 
malaria patients. The findings of  the present study were 
consistent with those of  previous studies in the literature. 
For example, a previous Nigerian study among pharmacists 
reported that years of  practice after graduation significantly 
influenced the quality of  PC practice33. Similarly, Asmelashe 
and colleagues, in Ethiopia, reported that sex was a significant 
determinant of  the involvement of  community pharmacists 
in certain pharmacy services. In this previous study, female 
pharmacists performed better than male pharmacists34. It 
is generally expected that pharmacists who possess many 
years of  experience in community pharmacy practice would 
perform better in the provision of  cognitive pharmacy 
services. With exposure to varied case scenarios in practice, 
pharmacists are well placed to provide extensive and quality 
medication-related services for the good of  their patients or 
clients. Therefore, our findings underscore the need for a 
concerted effort by the government, health policymakers, 
and community pharmacists to improve the participation 
of  pharmacists in the management of  malaria cases. 
Nigeria remains a malaria-endemic country; hence urgent 
action is required to address this menace from all avenues. 
Routine training and update courses are recommended for 
community pharmacists in Nigeria in order to enhance their 
knowledge and skills in handling malaria and other related 
cases. With the official launch of  the Doctor of  Pharmacy 
program in Nigeria, it is recommended that primary health 
care course work and experiential activities through vigorous 
clinical clerkship and hands-on training be included as part 
of  the curriculum in its schools of  pharmacy.
Study limitations
This study had some limitations that should be considered 
while interpreting its findings. First, this study was conducted 
in one of  the thirty-six states in Nigeria. Thus, its findings 
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might not represent the general views of  community 
pharmacists in Nigeria, although Enugu state, the former 
capital of  the Eastern region, has a mixed population of  
community pharmacists from various ethnic groups, social 
statuses, and educational backgrounds. Secondly, because of  
the cross-sectional study design, the current study could only 
determine factors associated with the level of  involvement 
of  community pharmacists in the management of  malaria 
cases.
Conclusion
Overall, more than half  of  the community pharmacists 
assessed in this study were satisfactorily involved in the 
management of  malaria cases. However, the number of  years 
of  practice and sex were factors associated with the extent 
of  participation in malaria case management. Improved 
awareness and knowledge of  the significance of  malaria 
case management among community pharmacists could 
be achieved by continuing education and training, public 
workshops, seminars, conferences, and short refresher 
courses. 
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